financetom
Business
financetom
/
Business
/
Jon Stewart will remain at the helm of 'The Daily Show' until next December
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jon Stewart will remain at the helm of 'The Daily Show' until next December
Nov 3, 2025 12:04 PM

Nov 3 (Reuters) - Paramount Skydance ( PSKY ) said on

Monday that comedian Jon Stewart will continue hosting Comedy

Central's "The Daily Show" every Monday and serve as executive

producer for the series until December next year.

The political comedian returned to "The Daily Show" as

executive producer and host in February last year. He stepped

down in 2015 and was replaced by comedian Trevor Noah.

Stewart will continue to host alongside "The Daily

Show's" news team, including Ronny Chieng, Josh Johnson and Desi

Lydic, who will share hosting from Tuesdays through Thursdays,

Paramount said in a statement.

The show, which has won 28 Emmy Awards in total since it

started airing in 1996, recorded its highest quarterly rating in

four years in the third quarter, according to data from Nielsen.

Stewart was among the many comedians and celebrities that

had rallied to support CBS' "Late Show" host Stephen Colbert

after the network canceled his show, with Stewart lashing out at

Paramount Global for the decision to end the long-running TV

program.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Is Home Furnishing Brand Lovesac Stock Plunging Today?
Why Is Home Furnishing Brand Lovesac Stock Plunging Today?
Apr 11, 2024
The Lovesac Company ( LOVE ) shares are plummeting on Thursday. The company reported fourth-quarter earnings per share of $1.87, missing the analyst consensus of $1.93. Quarterly revenues of $250.507 million missed the street view of $265.323 million. Sales rose 5% year over year, primarily driven by growth within showrooms and internet channels. Gross profit increased 11.9% to $149.6 million in the fourth quarter...
MorphoSys Board Supports Norvartis' Buyout Offer as Tender Period Begins
MorphoSys Board Supports Norvartis' Buyout Offer as Tender Period Begins
Apr 11, 2024
10:03 AM EDT, 04/11/2024 (MT Newswires) -- The MorphoSys ( MOR ) board on Thursday recommended shareholders accept the 2.7 billion-euro ($2.9 billion) buyout offer from Novartis ( NVS ) , saying it was in the best interest of the company, investors and potential patients. The deal, announced Feb. 5, values MorphoSys ( MOR ) at 68 euros per share,...
Update: Globe Life Shares Decline on Short Seller Report; No Immediate Company Comment
Update: Globe Life Shares Decline on Short Seller Report; No Immediate Company Comment
Apr 11, 2024
10:06 AM EDT, 04/11/2024 (MT Newswires) -- (Updates to add details throughout.) Globe Life ( GL ) shares were down more than 14% in recent Thursday trading after short-seller Fuzzy Panda Research alleged that company executives disregarded insurance fraud. Fuzzy Panda, which said it had a short position in Globe Life ( GL ) shares, alleged that the company's executives...
Eliem Therapeutics to Acquire Tenet Medicines; Launching Private Placement -- Eliem Shares Surge
Eliem Therapeutics to Acquire Tenet Medicines; Launching Private Placement -- Eliem Shares Surge
Apr 11, 2024
10:02 AM EDT, 04/11/2024 (MT Newswires) -- Eliem Therapeutics ( ELYM ) and Tenet Medicines said Thursday they have signed an agreement under which Eliem will buy the development-stage private biotech company. The combined company will focus on the development of TNT119, an antibody to potentially treat autoimmune diseases like systemic lupus erythematosus, immune thrombocytopenia and membranous nephropathy, the companies...
Copyright 2023-2026 - www.financetom.com All Rights Reserved